|
|
|
Insider
Information: |
Labrucherie Gil M |
Relationship: |
Chief Financial Officer |
City: |
San Carlos |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
319,155 |
|
Indirect Shares
|
94,335 |
|
|
Direct
Value |
$377,825 |
|
|
Indirect Value
|
$460,355 |
|
|
Total
Shares |
413,490 |
|
|
Total
Value |
$838,179 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Nektar Therapeutics |
NKTR |
SVP, COO & CFO |
2022-05-16 |
312,905 |
2008-11-14 |
0 |
Premium* |
|
Rezolute, Inc |
RZLT |
Director |
2022-05-04 |
0 |
2022-05-04 |
53,572 |
Premium* |
|
Acelyrin, Inc. |
SLRN |
Chief Financial Officer |
2023-10-04 |
6,250 |
2023-10-04 |
40,763 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
104 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
NKTR |
Nektar Therapeutics |
SVP, COO & CFO |
|
2019-11-18 |
4 |
S |
$17.97 |
$159,268 |
D/D |
(8,863) |
219,009 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP, COO & CFO |
|
2019-12-12 |
4 |
A |
$0.00 |
$0 |
D/D |
40,150 |
259,159 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP, COO & CFO |
|
2020-02-18 |
4 |
S |
$22.35 |
$132,714 |
D/D |
(5,938) |
253,221 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP, COO & CFO |
|
2020-05-18 |
4 |
AS |
$22.51 |
$128,915 |
D/D |
(5,727) |
247,494 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP, COO & CFO |
|
2020-05-19 |
4 |
AS |
$22.62 |
$45,240 |
D/D |
(2,000) |
245,494 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP, COO & CFO |
|
2020-08-17 |
4 |
AS |
$19.67 |
$122,839 |
D/D |
(6,245) |
239,249 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP, COO & CFO |
|
2020-08-18 |
4 |
AS |
$19.68 |
$39,360 |
D/D |
(2,000) |
237,249 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP, COO & CFO |
|
2020-09-17 |
4 |
AS |
$19.96 |
$39,920 |
D/D |
(2,000) |
235,249 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP, COO & CFO |
|
2020-11-16 |
4 |
S |
$16.93 |
$140,113 |
D/D |
(8,276) |
226,973 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP, COO & CFO |
|
2020-12-18 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
266,973 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP, COO & CFO |
|
2021-02-02 |
4 |
AS |
$19.97 |
$1,008,629 |
D/D |
(50,000) |
266,973 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP, COO & CFO |
|
2021-02-02 |
4 |
OE |
$8.80 |
$440,000 |
D/D |
50,000 |
316,973 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP, COO & CFO |
|
2021-02-03 |
4 |
AS |
$19.61 |
$980,500 |
D/D |
(50,000) |
266,973 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP, COO & CFO |
|
2021-02-03 |
4 |
OE |
$8.80 |
$440,000 |
D/D |
50,000 |
316,973 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP, COO & CFO |
|
2021-02-04 |
4 |
OE |
$8.80 |
$440,000 |
D/D |
50,000 |
316,973 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP, COO & CFO |
|
2021-02-04 |
4 |
AS |
$19.81 |
$990,500 |
D/D |
(50,000) |
266,973 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP, COO & CFO |
|
2021-02-16 |
4 |
S |
$22.37 |
$178,445 |
D/D |
(7,977) |
258,996 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP, COO & CFO |
|
2021-05-17 |
4 |
S |
$18.30 |
$144,533 |
D/D |
(7,898) |
251,098 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP, COO & CFO |
|
2021-08-16 |
4 |
AS |
$13.83 |
$108,801 |
D/D |
(7,867) |
243,231 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP, COO & CFO |
|
2021-08-17 |
4 |
AS |
$13.56 |
$40,680 |
D/D |
(3,000) |
240,231 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP, COO & CFO |
|
2021-11-15 |
4 |
A |
$0.00 |
$0 |
D/D |
40,150 |
280,831 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP, COO & CFO |
|
2021-11-16 |
4 |
AS |
$13.16 |
$278,321 |
D/D |
(21,149) |
259,682 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP, COO & CFO |
|
2021-11-18 |
4 |
AS |
$12.69 |
$38,070 |
D/D |
(3,000) |
256,682 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP, COO & CFO |
|
2021-12-16 |
4 |
A |
$0.00 |
$0 |
D/D |
52,950 |
309,182 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP, COO & CFO |
|
2022-02-16 |
4 |
S |
$10.95 |
$82,990 |
D/D |
(7,579) |
301,603 |
0 |
- |
|
104 Records found
|
|
Page 4 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|